Alzheimer’s disease: targeting the glutamatergic system

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1573-6768

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Alzheimer’s disease: targeting the glutamatergic system ; volume:21 ; number:3 ; day:11 ; month:2 ; year:2020 ; pages:257-274 ; date:6.2020
Biogerontology ; 21, Heft 3 (11.2.2020), 257-274, 6.2020

Creator: Conway, Myra E.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s10522-020-09860-4

URN: urn:nbn:de:101:1-2020071200482119996966

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:51 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Conway, Myra E.
SpringerLink (Online service)

Other Objects (12)

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Alzheimer’s disease: targeting the peripheral circulation

Targeting psychologic stress signaling pathways in Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

Alzheimer’s Disease

The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons

Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease

miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1

Aufsatzsammlung

Alzheimer's disease

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Alzheimer’s disease: targeting the peripheral circulation

Targeting psychologic stress signaling pathways in Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

Alzheimer’s Disease

The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons

Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease

miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1

Aufsatzsammlung

Alzheimer's disease

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Alzheimer’s disease: targeting the peripheral circulation

Targeting psychologic stress signaling pathways in Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

Alzheimer’s Disease

The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons

Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease

miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1

Aufsatzsammlung

Alzheimer's disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Alzheimer’s disease: targeting the glutamatergic system

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Alzheimer’s disease: targeting the peripheral circulation

Targeting psychologic stress signaling pathways in Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

Alzheimer’s Disease

The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons

Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease

miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1

Alzheimer's disease

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Alzheimer’s disease: targeting the peripheral circulation

Targeting psychologic stress signaling pathways in Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

Alzheimer’s Disease

The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons

Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease

miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1

Alzheimer's disease

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Alzheimer’s disease: targeting the peripheral circulation

Targeting psychologic stress signaling pathways in Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

Alzheimer’s Disease

The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons

Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease

miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1

Alzheimer's disease

Related objects

Reset password